Azimuth Capital Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$4.77M Buy
71,963
+2,845
+4% +$189K 0.2% 154
2021
Q4
$4.03M Sell
69,118
-570
-0.8% -$33.2K 0.16% 163
2021
Q3
$4.19M Buy
69,688
+780
+1% +$46.8K 0.18% 158
2021
Q2
$4.13M Buy
68,908
+3,810
+6% +$228K 0.18% 165
2021
Q1
$3.24M Buy
65,098
+3,975
+7% +$198K 0.15% 179
2020
Q4
$3.06M Buy
61,123
+2,899
+5% +$145K 0.15% 172
2020
Q3
$3.19M Buy
58,224
+350
+0.6% +$19.2K 0.19% 143
2020
Q2
$3.06M Sell
57,874
-803
-1% -$42.5K 0.19% 136
2020
Q1
$2.62M Sell
58,677
-140
-0.2% -$6.25K 0.2% 136
2019
Q4
$2.93M Sell
58,817
-165
-0.3% -$8.23K 0.18% 157
2019
Q3
$2.63M Buy
58,982
+820
+1% +$36.6K 0.17% 158
2019
Q2
$2.4M Sell
58,162
-135
-0.2% -$5.57K 0.16% 163
2019
Q1
$2.36M Sell
58,297
-34,646
-37% -$1.4M 0.16% 162
2018
Q4
$3.53M Sell
92,943
-835
-0.9% -$31.7K 0.27% 120
2018
Q3
$3.71M Sell
93,778
-4,350
-4% -$172K 0.25% 126
2018
Q2
$3.45M Sell
98,128
-3,588
-4% -$126K 0.25% 133
2018
Q1
$3.56M Sell
101,716
-9,999
-9% -$350K 0.26% 132
2017
Q4
$3.88M Buy
111,715
+6,395
+6% +$222K 0.28% 128
2017
Q3
$3.57M Buy
105,320
+4,550
+5% +$154K 0.27% 131
2017
Q2
$3.44M Buy
100,770
+2,280
+2% +$77.7K 0.27% 127
2017
Q1
$3.07M Buy
98,490
+4,582
+5% +$143K 0.25% 141
2016
Q4
$2.57M Sell
93,908
-3,830
-4% -$105K 0.22% 148
2016
Q3
$3.21M Buy
97,738
+770
+0.8% +$25.3K 0.28% 117
2016
Q2
$2.93M Buy
96,968
+4,340
+5% +$131K 0.26% 126
2016
Q1
$2.61M Buy
92,628
+4,425
+5% +$125K 0.25% 128
2015
Q4
$2.99M Buy
88,203
+5,500
+7% +$187K 0.29% 119
2015
Q3
$2.63M Sell
82,703
-6,785
-8% -$216K 0.28% 123
2015
Q2
$2.85M Buy
89,488
+1,800
+2% +$57.3K 0.28% 123
2015
Q1
$3M Buy
87,688
+38,404
+78% +$1.31M 0.29% 114
2014
Q4
$1.73M Buy
49,284
+4,570
+10% +$161K 0.18% 156
2014
Q3
$1.6M Buy
44,714
+3,200
+8% +$114K 0.18% 158
2014
Q2
$1.54M Buy
41,514
+2,086
+5% +$77.5K 0.17% 159
2014
Q1
$1.28M Buy
39,428
+518
+1% +$16.8K 0.15% 163
2013
Q4
$1.16M Buy
+38,910
New +$1.16M 0.14% 161